Siemens Healthineers AG (FRA:SHL1)

Market Cap	47.05B -19.3%
Revenue (ttm)	23.38B +4.5%
Net Income	2.14B +10.4%
EPS	1.91 +10.4%
Shares Out	n/a
PE Ratio	21.95
Forward PE	17.68
Dividend	0.35 (1.62%)
Ex-Dividend Date	Feb 9, 2026

Volume	30
Average Volume	4
Open	20.60
Previous Close	20.80
Day's Range	20.60 - 21.60
52-Week Range	20.00 - 28.80
Beta	n/a
RSI	46.28
Earnings Date	Feb 5, 2026

About Siemens Healthineers AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the readin...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1896
• Employees: 73,840
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SHL1

Financial Performance

In fiscal year 2025, Siemens Healthineers AG's revenue was 23.38 billion, an increase of 4.53% compared to the previous year's 22.36 billion. Earnings were 2.14 billion, an increase of 10.40%.